Orlov S. Nicole Schaeffer - Jan 30, 2025 Form 4 Insider Report for INSMED Inc (INSM)

Signature
/s/ S. Nicole Schaeffer, by Michael A. Smith as Attorney-in-fact
Stock symbol
INSM
Transactions as of
Jan 30, 2025
Transactions value $
-$5,920,816
Form type
4
Date filed
1/31/2025, 04:33 PM
Previous filing
Jan 16, 2025
Next filing
Feb 7, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSM Common Stock Options Exercise $808K +50K +51.5% $16.16 147K Jan 30, 2025 Direct F1
transaction INSM Common Stock Options Exercise $562K +41.1K +27.97% $13.67 188K Jan 30, 2025 Direct F1
transaction INSM Common Stock Sale -$7.29M -91.1K -48.42% $80.00 97.1K Jan 30, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSM Stock Option (right to buy) Options Exercise $0 -50K -100% $0.00 0 Jan 30, 2025 Common Stock 50K $16.16 Direct F1, F2
transaction INSM Stock Option (right to buy) Options Exercise $0 -41.1K -100% $0.00 0 Jan 30, 2025 Common Stock 41.1K $13.67 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2 The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.